-
EP3415517
European procedure
Extract from the Register of European Patents
EP About this file: EP3415517
| EP3415517 - CRYSTALLINE FORM OF 1-(4-1-(2,6-DIFLUOROBENZYL)-5-DIMETHYLAMINOMETHYL-3-(6-METHOXYPYRIDAZIN-3-YL)-2,4-DIOXO-1,2,3,4-TETRAHYDROTHIENO(2,3-D)-PYRIMIDIN-6YL)PHENYL)-3-METHOXYUREA [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 24.02.2023 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 18.03.2022 | ||
| Former | Grant of patent is intended Status updated on 03.11.2021 | ||
| Former | Examination is in progress Status updated on 14.09.2021 | ||
| Former | Grant of patent is intended Status updated on 02.05.2021 | ||
| Former | Examination is in progress Status updated on 29.03.2021 | ||
| Former | Grant of patent is intended Status updated on 16.11.2020 | ||
| Former | Examination is in progress Status updated on 24.02.2020 | ||
| Former | Request for examination was made Status updated on 07.06.2019 | ||
| Former | The application has been published Status updated on 16.11.2018 | Most recent event Tooltip | 24.02.2023 | No opposition filed within time limit | published on 29.03.2023 [2023/13] | Applicant(s) | For all designated states Takeda Pharmaceutical Company Limited 1-1, Doshomachi 4-chome Chuo-ku Osaka-shi Osaka 541-0045 / JP | [2018/51] | Inventor(s) | 01 /
MIWA, Kazuhiro TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85 Jusohonmachi 2-chome Yodogawa-ku Osaka-shi, Osaka 532-0024 / JP | 02 /
SASAKI, Tsuyoshi TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85 Jusohonmachi 2-chome Yodogawa-ku Osaka-shi, Osaka 532-0024 / JP | 03 /
KOMURA, Fumiya TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85 Jusohonmachi 2-chome Yodogawa-ku Osaka-shi, Osaka 532-0024 / JP | [2018/51] | Representative(s) | Elkington and Fife LLP Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR / GB | [2022/16] |
| Former [2018/51] | Elkington & Fife LLP Prospect House 8 Pembroke Road Sevenoaks Kent TN13 1XR / GB | Application number, filing date | 18185835.8 | 27.09.2013 | [2018/51] | Priority number, date | JP20120217679 | 28.09.2012 Original published format: JP 2012217679 | [2018/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3415517 | Date: | 19.12.2018 | Language: | EN | [2018/51] | Type: | B1 Patent specification | No.: | EP3415517 | Date: | 20.04.2022 | Language: | EN | [2022/16] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 09.11.2018 | Classification | IPC: | C07D495/04, A61P5/02, A61P15/08 | [2020/46] | CPC: |
C07D495/04 (EP,CN,US);
C07D333/38 (CN,US);
C07D409/12 (US)
|
| Former IPC [2018/51] | C07D495/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/28] |
| Former [2018/51] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | KRISTALLINE FORM VON 1-(4-1-(2,6-DIFLUOROBENZYL)-5-DIMETHYLAMINOMETHYL-3-(6-METHOXYPYRIDAZIN-3-YL)-2,4-DIOXO-1,2,3,4-TETRAHYDROTHIENO(2,3-D)-PYRIMIDIN-6YL)PHENYL)-3-METHOXYUREA | [2018/51] | English: | CRYSTALLINE FORM OF 1-(4-1-(2,6-DIFLUOROBENZYL)-5-DIMETHYLAMINOMETHYL-3-(6-METHOXYPYRIDAZIN-3-YL)-2,4-DIOXO-1,2,3,4-TETRAHYDROTHIENO(2,3-D)-PYRIMIDIN-6YL)PHENYL)-3-METHOXYUREA | [2018/51] | French: | FORME CRISTALLINE DU 1-(4-1-(2,6-DIFLUOROBENZYL)-5-DIMETHYLAMINOMETHYL-3-(6-METHOXYPYRIDAZIN-3-YL)-2,4-DIOXO-1,2,3,4-TETRAHYDROTHIENO(2,3-D)-PYRIMIDIN-6YL)PHENYL)-3-METHOXYUREA | [2018/51] | Examination procedure | 04.06.2019 | Examination requested [2019/28] | 04.06.2019 | Date on which the examining division has become responsible | 29.07.2019 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 27.09.2019 | Amendment by applicant (claims and/or description) | 27.02.2020 | Despatch of a communication from the examining division (Time limit: M06) | 02.09.2020 | Reply to a communication from the examining division | 17.11.2020 | Communication of intention to grant the patent | 26.03.2021 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 03.05.2021 | Communication of intention to grant the patent | 10.09.2021 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 04.11.2021 | Communication of intention to grant the patent | 09.03.2022 | Fee for grant paid | 09.03.2022 | Fee for publishing/printing paid | 09.03.2022 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP13779938.3 / EP2900675 | Divisional application(s) | EP22168256.0 / EP4119564 | Opposition(s) | 23.01.2023 | No opposition filed within time limit [2023/13] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 30.09.2019 | Request for further processing filed | 30.09.2019 | Full payment received (date of receipt of payment) Request granted | 11.10.2019 | Decision despatched | Fees paid | Renewal fee | 26.07.2018 | Renewal fee patent year 03 | 26.07.2018 | Renewal fee patent year 04 | 26.07.2018 | Renewal fee patent year 05 | 26.07.2018 | Renewal fee patent year 06 | 11.09.2019 | Renewal fee patent year 07 | 11.09.2020 | Renewal fee patent year 08 | 22.09.2021 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]EP1591446 (TAKEDA CHEMICAL INDUSTRIES LTD [JP]); | by applicant | WO0056739 | WO2004067535 |